{"id":"W2903347258","doi":"10.2337/dc18-1491","title":"Inclisiran Lowers LDL-C and PCSK9 Irrespective of Diabetes Status: The ORION-1 Randomized Clinical Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Care","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Esperion Therapeutics; Ionis Pharmaceuticals; Mylan; Novo Nordisk; Medicines Company; Sanofi; Kowa Company; Regeneron Pharmaceuticals; Eli Lilly and Company; AstraZeneca; CSL Behring; Amgen; Pfizer","keywords":"PCSK9; Medicine; Diabetes mellitus; Dyslipidemia; Internal medicine; Placebo; Adverse effect; Cholesterol; Endocrinology; Type 2 diabetes; Apolipoprotein B; Randomized controlled trial; Lipoprotein; Gastroenterology; LDL receptor; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002972065,0.0002050053,0.001303462,0.0000823619,0.0001554236,0.00002705615,0.0001205109,0.0001713316,0.00005693639],"category_scores_gemma":[0.002446336,0.0001204698,0.0006909915,0.0002224035,0.001040592,0.00006321254,0.000107361,0.0003118173,0.00002185227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005534105,"about_ca_system_score_gemma":0.0002256954,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000564659,"about_ca_topic_score_gemma":0.00002404581,"domain_scores_codex":[0.9971684,0.0008243666,0.0006752728,0.0003849996,0.0005035388,0.0004434339],"domain_scores_gemma":[0.997313,0.00109693,0.0002143831,0.0006939815,0.0004542206,0.0002274966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1678209,0.0003214907,0.5375378,0.0007519106,0.003206458,0.000007205686,0.008820092,6.791343e-7,0.0002906883,0.0003933029,0.001215301,0.2796343],"study_design_scores_gemma":[0.880963,0.004497923,0.08735508,0.0003966645,0.001557453,9.466861e-7,0.005307061,0.0001354191,0.003486913,0.0005067526,0.01544878,0.0003440123],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9890532,0.005633707,0.00001035907,0.0003105529,0.0009089328,0.002411426,0.00005369273,0.00004262751,0.001575425],"genre_scores_gemma":[0.9969428,0.0002838562,0.000161257,0.0006421763,0.001762594,0.000115695,0.00003627726,0.00003076195,0.0000245936],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7131421,"threshold_uncertainty_score":0.4912614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02028013790582422,"score_gpt":0.3205581695925471,"score_spread":0.3002780316867228,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}